SCHEDULE 13D

Company

PTC THERAPEUTICS, INC.

Filed

May 24, 2019

Accession Number

0001144204-19-028176

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →